// App-Quantinova.ai

: Hypofractionated, accelerated radiotherapy to the prostate bed: Five-year outcomes of a prospective phase I/II study.

Researchers

Presenter

  • Kevin Martell

Principal Investigators

  • Patrick Cheung

  • Gerard Morton

  • Hans T. Chung

  • Andrea Deabreu

  • Liying Zhang

  • Geordi Pang

  • Yasir Alayed

  • Alexandre Mamedov

  • Adam Gladwish

  • Andrew Loblaw

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Toronto-Sunnybrook Reg Cancer Centre, Toronto, ON, Canada

  • Simcoe Muskoka Regional Cancer Program, Barrie, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A